Sanofi (EPA: SAN)
France
· Delayed Price · Currency is EUR
94.73
-0.98 (-1.02%)
Nov 12, 2024, 5:38 PM CET
Sanofi Revenue
Sanofi had revenue of 14.16B EUR in the quarter ending September 30, 2024, with 11.49% growth. This brings the company's revenue in the last twelve months to 48.45B, up 6.01% year-over-year. In the year 2023, Sanofi had annual revenue of 46.03B with 1.42% growth.
Revenue (ttm)
48.45B
Revenue Growth
+6.01%
P/S Ratio
2.45
Revenue / Employee
562.74K
Employees
86,088
Market Cap
118.75B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 46.03B | 644.00M | 1.42% |
Dec 31, 2022 | 45.39B | 6.21B | 15.86% |
Dec 31, 2021 | 39.18B | 1.81B | 4.83% |
Dec 31, 2020 | 37.37B | -262.00M | -0.70% |
Dec 31, 2019 | 37.63B | 1.95B | 5.48% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
EssilorLuxottica Société anonyme | 25.83B |
Sartorius Stedim Biotech S.A. | 2.74B |
bioMérieux S.A. | 3.81B |
Ipsen S.A. | 3.44B |
Eurofins Scientific SE | 6.72B |
Virbac SA | 1.34B |
Ramsay Générale de Santé SA | 5.01B |
Vetoquinol SA | 537.47M |
Sanofi News
- 1 day ago - CEO of pharma giant Sanofi says businesses should stop ‘AI washing’ - Fortune
- 5 days ago - The Accumulus Platform Powers Sanofi's Submissions to Multiple Regulators Around the World - GlobeNewsWire
- 7 days ago - Press Release: Dupixent approved in the EU as the first and only medicine for young children with eosinophilic esophagitis - GlobeNewsWire
- 7 days ago - SandboxAQ CEO on the firm's partnership with Sanofi - CNBC
- 12 days ago - Vir Biotechnology Reports Third Quarter 2024 Financial Results and Provides Corporate Update - Benzinga
- 12 days ago - Novavax Q3 Earnings A Week Away - Time To Accept A New Reality - Seeking Alpha
- 13 days ago - Sanofi Cancels Consumer Healthcare Business Spin-Off - Forbes
- 15 days ago - Resalis Therapeutics Gains Strategic Equity Investment from Sanofi - Business Wire